AGEN | InformativeNASDAQ:AGEN
If it passes the bearish line it's time for a short position, and if it passes the bullish line it's time for the Long position, the price targets are on the chart.
AGEN
AGEN Stock reversalNASDAQ:AGEN I am looking for a strong trend reversal in the near future (1-2 months). I would start adding to positions slowly at these levels. PT = $6 + this year.
AGEN Daily TimeframeSNIPER STRATEGY (new version)
It works ALMOST ON ANY CHART.
It produces Weak, Medium and Strong signals based on consisting elements.
NOT ALL TARGETS CAN BE ACHIEVED, let's make that clear.
TARGETS OR ENTRY PRICES ARE STRONG SUPPORT AND RESISTANCE LEVELS.
ENTRY PRICE BLACK COLOR
TARGETS GREEN COLOR
STOP LOSS RED COLOR
DO NOT USE THIS STROTEGY FOR LEVERAGED TRADING.
It will not give you the whole wave like any other strategy out there but it will give you a huge part of the wave.
The BEST TIMEFRAMES for this strategy are Daily, Weekly and Monthly however it can work on any timeframe.
Consider those points and you will have a huge advantage in the market.
There is a lot more about this strategy.
It can predict possible target and also give you almost exact buy or sell time on the spot.
I am developing it even more so stay tuned and start to follow me for more signals and forecasts.
START BELIEVING AND GOOD LUCK
HADIMOZAYAN
AGEN digging through the CratesAGEN hasn't done this in years...what? It hasn't sustained these levels for any meaningful amount of time. I did a quick fib retracement using those 2017 highs as the upper anchor and you can see what has revealed itself. The 236 area is a key pivot. Most of the time it has acted as a resistance pivot. But, so far AGEN has held these levels. Where does it go from here? A lot of that might have to do with what's coming.
" pipeline treatments like AGEN1777 have gained interest from some of the industry’s leading names. Bristol Myers Squibb ( BMY ) has a global exclusive license with Agenus providing up to $200 million in cash upfront. The company can also receive up to $1.36 billion if it reaches specific milestones and includes royalties upon any sales. The FDA already cleared an Investigational New Drug Application for a Phase 1 dosing with AGEN1777 alone and combined with an anti-PD-1 in solid tumors. That’s expected to begin this quarter...Balstilimab...is something that could be in focus as well. The FDA accepted a Biologics License Application for priority review. A Prescription Drug User Fee Act (PDUFA) target date was also given. December 16th will be the PDUFA date and could present an important one for the company and Balstilimab. Phase 2 data showed a response rate of 20% in PD-L1 positive tumors, an overall response rate of 15%, and a median duration of response of 15.4 months. Furthermore, Phase 2 trial results of balstilimab combined with zalifrelimab (AGEN1884) will be presented at a Mini Oral Session at the European Society for Medical Oncology Congress next month. So plenty to watch if AGEN stock is on your watch list right now. "
Quote Source & Read more On AGEN: Hot Biotech Stocks That Deserve Your Attention In August 2021
short term +1,000%Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally.
agen breaking out of downward trend looking at 2 potential targeCheck the chart. Like, follow, and enjoy! Cheers!
AGEN: ready to launchAGEN has retraced 61.8% of the first impulse leg higher and is ready to rally again.
AGEN gets approval from FDA 5-14Thinking it was gonna go north today ? No such luck.
I believe Monday will be the kickstart that's needed to begin its run for the short. Climbing on Monday over the the 2.50s, only to come back to the high to mid 2.40s. Then the next two days, Tuesday and Wednesday, will be good gain days, full bullish days and maybe Friday as well. Fundamentals are primed and Techs look good as well. Hoping for a public announcements from " The Company" this coming week ? Will there be ? Not that I've heard or researched as of yet, NO. But ill update if there is one.
AGEN GOING TO RETEST THE LONG TERM RESISTANCE?AGEN is still in a downtrend. Looking to the previous bounce it could be a retest of the long term resistance. If it can't break the level posted on chart (3$ - 3,25$) i'm expecting one more bearish move.
AGEN: at old time support! Be a Lynch!Is it going to bounce and go 10 bagger?
Thanks Mr. Peter Lynch.
This is an opinion... don't trade without due diligence.
AGENLearning Fib. levels (entry levels): Fib. proposed this entry (4.55) on 29.04.18, I woulda proposed 3.70
Agenus OpportunityLooking for a buy opportunity in this. Right now I am not in it.
In a down trend here.... lets see how low it goes.
Support and Resistance at $4.23?
AGEN - Breakout momentum Long from $4.69 AGEN is breaking through a lot os label of resistance. In longer therm its been declining from $10 & now getting some strength, and money flow is very strong now.
It has huge insider buying from another Biotechnology company. We think it has very good upside potential.
* Trade Criteria *
Date First Found- July 17, 2017
Pattern/Why- Flag formation momentum long
Entry Target Criteria- Break of $4.69
Exit Target Criteria- Momentum
Stop Loss Criteria- $4.07
Please check back for Trade updates. (Note: Trade update is little delayed here.)
AEGN COVERED CALLThis little fella popped up on my radar earlier today as having high implied volatility, so I pretty much blindly put on the covered call then and there, buying 100 shares a 6.24 and selling the Sept 16th 7 put for a 5.77 debit (which will be my cost basis in the shares).
The max profit is $123 with a ROC of about 21.3% (assuming a call away at 7).
